AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2025
Feb 3, 2025
30718_dirs_2025-02-03_d5081e1c-45b0-4081-b9e0-484146f5f02d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2024-08-15
Reporting Person: McManus Matthew (President - DGS)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-08-15 | Performance Restricted Stock Units | $ | A | 15825 | Acquired | Common Stock (15825) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4